The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Brain-Derived Neurotrophic Factor Is Required for the Establishment of the Proper Number of Dopaminergic Neurons in the Substantia Nigra Pars Compacta
Open accessAbstract
Brain-derived neurotrophic factor (BDNF) has been implicated in regulating neuronal survival, differentiation, and synaptic plasticity. Reduced expression of BDNF within the substantia nigra accompanies the deterioration of dopaminergic neurons in Parkinson's disease (PD) patients. Analysis of the effects of long-term BDNF absence from the CNS has been difficult because of the early postnatal lethality of BDNF-/-mice. Mice with a floxed BDNF allele were bred with Wnt1-Cre mice to generate Wnt-BDNF KOmice that lack BDNF from the midbrain-hindbrain (MHB). These mice are viable but exhibit hindlimb clutching and poor rotarod performance. Tyrosine hydroxylase (TH)-positive neuron numbers in the substantia nigra pars compacta (SNC) were estimated using stereological methods, revealing a persistent ∼23% reduction of these cells at postnatal day 21 (P21) in Wnt-BDNF KOmice compared with controls. The diminishment of TH-expressing neurons was present at birth and continued through P120. This deficit appears selective for the dopaminergic population, because at P21, total neuron number within the SNC, defined as neuronal nuclei protein-positive cells, was not significantly reduced. Interestingly, and similar to observations in PD patients, SNC neuron subpopulations are not equally affected. Calbindin- and calretinin-expressing SNC populations show no significant difference between Wnt-BDNF KOmice and controls. Thus, BDNF depletion from the MHB selectively leads to reduced TH expression in a subpopulation of neurons, but it remains unclear whether these cells are lost.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 4,859
Neurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394
GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons
Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S., & Collins, F. (1993) · Science · doi:10.1126/science.8493557 · Cited by 3,205
West, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994
GUNDERSEN, H. J. G., BENDTSEN, T. F., KORBO, L., MARCUSSEN, N., MØLLER, A., NIELSEN, K., NYENGAARD, J. R., PAKKENBERG, B., SØRENSEN, F. B., VESTERBY, A., et al. (1988) · APMIS · doi:10.1111/j.1699-0463.1988.tb05320.x · Cited by 2,929
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K., & Seitelberger, F. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90175-5 · Cited by 2,651
Cellular Scaling Rules for the Brains of Marsupials: Not as “Primitive” as Expected
Dos Santos, S. E., Porfirio, J., da Cunha, F. B., Manger, P. R., Tavares, W., Pessoa, L., Raghanti, M. A., Sherwood, C. C., & Herculano-Houzel, S. (2017) · Brain, Behavior and Evolution · doi:10.1159/000452856 · Cited by 2,642
NeuN, a neuronal specific nuclear protein in vertebratesxs
Mullen, R. J., Buck, C. R., & Smith, A. M. (1992) · Development · doi:10.1242/dev.116.1.201 · Cited by 2,351
A Drosophila model of Parkinson's disease
Feany, M. B., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,118
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024 · cited 2×
“In ϳ10% of cases, the disease is associated with a genetic defect (Goldman and Tanner, 1998) in genes, including ␣-synuclein, parkin, or DJ-1 (Feany and Bender, 2000; Shimura et al., 2000; Lotharius and Brundin, 2002).”
BackgroundThe substantia nigra of the human brain
Damier, P., Hirsch, E. C., Agid, Y., & Graybiel, A. M. (1999) · Brain · doi:10.1093/brain/122.8.1437 · Cited by 1,756
BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra
Hyman, C., Hofer, M., Barde, Y.-A., Juhasz, M., Yancopoulos, G. D., Squinto, S. P., & Lindsay, R. M. (1991) · Nature · doi:10.1038/350230a0 · Cited by 1,494
Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis
Chai, Y., Jiang, X., Ito, Y., Bringas, P., Han, J., Rowitch, D. H., Soriano, P., McMahon, A. P., & Sucov, H. M. (2000) · Development · doi:10.1242/dev.127.8.1671 · Cited by 1,465
Danielian, P. S., Muccino, D., Rowitch, D. H., Michael, S. K., & McMahon, A. P. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00562-3 · Cited by 1,293
Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein
Lotharius, J., & Brundin, P. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn983 · Cited by 1,283
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
Tomac, A., Lindqvist, E., Lin, L.-F. H., Ögren, S. O., Young, D., Hoffer, B. J., & Olson, L. (1995) · Nature · doi:10.1038/373335a0 · Cited by 1,079
Trk receptors: mediators of neurotrophin action
Patapoutian, A., & Reichardt, L. F. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00208-7 · Cited by 1,069
Jones, K. R., Fariñas, I., Backus, C., & Reichardt, L. F. (1994) · Cell · doi:10.1016/0092-8674(94)90377-8 · Cited by 1,042
Self-citationHuntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes
Zuccato, C., Tartari, M., Crotti, A., Goffredo, D., Valenza, M., Conti, L., Cataudella, T., Leavitt, B. R., Hayden, M. R., Timmusk, T., et al. (2003) · Nature Genetics · doi:10.1038/ng1219 · Cited by 979 · cited 1×
“F KO ; gray bars , heterozygous ; black bars , wild type . regulator of BDNF transcription ( Zuccato et al .”
BackgroundDescription of Parkinson's Disease as a Clinical Syndrome
FAHN, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07458.x · Cited by 977
Murer, M. G., Yan, Q., & Raisman-Vozari, R. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00014-9 · Cited by 874 · cited 2×
“BDNF stimulates dopamine activity and turnover in vitro and in vivo and is hypothesized to play a role in the mechanisms that allow the surviving DA neurons in early stage PD patients to compensate for cell losses (Blochl and Sirrenberg, 1996; Murer et al., 2001).”
BackgroundParkinson’s Disease and Movement Disorders
(2005) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/10587 · Cited by 798
Crawley, J. N. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01258-x · Cited by 761
The substantia nigra of the human brain
Damier, P., Hirsch, E. C., Agid, Y., & Graybiel, A. M. (1999) · Brain · doi:10.1093/brain/122.8.1421 · Cited by 578
Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra
Howells, D. W., Porritt, M. J., Wong, J. Y. F., Batchelor, P. E., Kalnins, R., Hughes, A. J., & Donnan, G. A. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7483 · Cited by 513
Disruption of the nuclear hormone receptor RORα in staggerer mice
Hamilton, B. A., Frankel, W. N., Kerrebrock, A. W., Hawkins, T. L., FitzHugh, W., Kusumi, K., Russell, L. B., Mueller, K. L., van Berkel, V., Birren, B. W., et al. (1996) · Nature · doi:10.1038/379736a0 · Cited by 492
Yamada, T., McGeer, P. L., Baimbridge, K. G., & McGeer, E. G. (1990) · Brain Research · doi:10.1016/0006-8993(90)91236-a · Cited by 448
Baquet, Z. C., Gorski, J. A., & Jones, K. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3920-03.2004 · Cited by 414
Self-citationBrain-Derived Neurotrophic Factor Is Required for the Maintenance of Cortical Dendrites
Gorski, J. A., Zeiler, S. R., Tamowski, S., & Jones, K. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-17-06856.2003 · Cited by 411
Self-citationMogi, M., Togari, A., Kondo, T., Mizuno, Y., Komure, O., Kuno, S., Ichinose, H., & Nagatsu, T. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00463-2 · Cited by 392
Hyman, C., Juhasz, M., Jackson, C., Wright, P., Ip, N., & Lindsay, R. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-01-00335.1994 · Cited by 373
Gerfen, C., Baimbridge, K., & Thibault, J. (1987) · The Journal of Neuroscience · doi:10.1523/jneurosci.07-12-03935.1987 · Cited by 338
GERMAN, D. C., MANAYE, K. F., SONSALLA, P. K., & BROOKS, B. A. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb24523.x · Cited by 318
Parain, K., Murer, M. G., Yan, Q., Faucheux, B., Agid, Y., Hirsch, E., & Raisman-Vozari, R. (1999) · NeuroReport · doi:10.1097/00001756-199902250-00021 · Cited by 303
Seroogy, K. B., Lundgren, K. H., Tran, T. M. D., Guthrie, K. M., Isackson, P. J., & Gall, C. M. (1994) · Journal of Comparative Neurology · doi:10.1002/cne.903420302 · Cited by 294
Levivier, M., Przedborski, S., Bencsics, C., & Kang, U. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-12-07810.1995 · Cited by 274 · cited 3×
“In vitro and in vivo, BDNF protects DA neurons from the toxic effects of low levels of the neurotoxins 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 6 OHDA (Levivier et al., 1995; Shults et al., 1995; Hung and Lee, 1996; for review, see Murer et al., 2001).”
BackgroundEtiology of Parkinson’s disease
Schapira, A. H. V. (2006) · Neurology · doi:10.1212/wnl.66.10_suppl_4.s10 · Cited by 250
TrkB receptor signaling is required for establishment of GABAergic synapses in the cerebellum
Rico, B., Xu, B., & Reichardt, L. F. (2002) · Nature Neuroscience · doi:10.1038/nn808 · Cited by 230
Liebl, D. J., Tessarollo, L., Palko, M. E., & Parada, L. F. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-23-09113.1997 · Cited by 217
Chauhan, N. B., Siegel, G. J., & Lee, J. M. (2001) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(01)00115-6 · Cited by 207
Complex relationship between Parkin mutations and Parkinson disease
West, A., Periquet, M., Lincoln, S., Lücking, C. B., Nicholl, D., Bonifati, V., Rawal, N., Gasser, T., Lohmann, E., Deleuze, J., et al. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10525 · Cited by 203
Axonal sprouting following lesions of the rat substantia nigra
Finkelstein, D. I., Stanic*, D., Parish, C. L., Tomas, D., Dickson, K., & Horne, M. K. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00009-9 · Cited by 201
Guidetti, P., Charles, V., Chen, E.-Y., Reddy, P. H., Kordower, J. H., Whetsell, W. O., Schwarcz, R., & Tagle, D. A. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7626 · Cited by 198
Son, J. H., Chun, H. S., Joh, T. H., Cho, S., Conti, B., & Lee, J. W. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-01-00010.1999 · Cited by 194
Neurotrophin Regulation of the Developing Nervous System: Analyses of Knockout Mice
Conover, J. C., & Yancopoulos, G. D. (1997) · Reviews in the Neurosciences · doi:10.1515/revneuro.1997.8.1.13 · Cited by 184
Time of neuron origin and gradients of neurogenesis in midbrain dopaminergic neurons in the mouse
Bayer, S., Wills, K., Triarhou, L., & Ghetti, B. (1995) · Experimental Brain Research · doi:10.1007/bf00240955 · Cited by 182
Blöchl, A., & Sirrenberg, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.35.21100 · Cited by 182
Gonz�lez-Hern�ndez, T., & Rodr�guez, M. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000522)421:1<107::aid-cne7>3.0.co;2-f · Cited by 182
Ernfors, P., Kučera, J., Lee, K., Loring, J. M., & Jaenisch, R. (1995) · The International Journal of Developmental Biology · doi:10.1387/ijdb.8645564 · Cited by 171
Migration of dopaminergic neurons in the embryonic mesencephalon of mice
Kawano, H., Ohyama, K., Kawamura, K., & Nagatsu, I. (1995) · Developmental Brain Research · doi:10.1016/0165-3806(95)00018-9 · Cited by 163
Parkin and the Molecular Pathways of Parkinson's Disease
Giasson, B. I., & Lee, V. M.-Y. (2001) · Neuron · doi:10.1016/s0896-6273(01)00439-1 · Cited by 159
Behavior and mutagenesis screens: The importance of baseline analysis of inbred strains
Tarantino, L. M., Gould, T. J., Druhan, J. P., & Bucan, M. (2000) · Mammalian Genome · doi:10.1007/s003350010107 · Cited by 158 · cited 1×
“Comparison of the slope of the lines, a measure of motor skill acquisition (Crawley, 1999; Tarantino et al., 2000), indicates that mutant and wild-type mice learn at similar rates.”
BackgroundOkazawa, H., Murata, M., Watanabe, M., Kamei, M., & Kanazawa, I. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81430-t · Cited by 147
Numan, S., & Seroogy, K. B. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990118)403:3<295::aid-cne2>3.0.co;2-l · Cited by 145
Developmental cell death in dopaminergic neurons of the substantia nigra of mice
Jackson-Lewis, V. R., Vila, M., Djaldetti, R., Guégan, C., Liberatore, G. T., Liu, J., O’Malley, K. L., Burke, R. E., & Przedborski, S. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20000828)424:3<476::aid-cne6>3.0.co;2-0 · Cited by 145
Auerbach, W., Hurlbert, M. S., Hilditch-Maguire, P., Wadghiri, Y. Z., Wheeler, V. C., Cohen, S. I., Joyner, A. L., MacDonald, M. E., & Turnbull, D. H. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.22.2515 · Cited by 144
Jordan, J. F., Böttner, M., Schluesener, H. J., Unsicker, K., & KRIEGLSTEIN, K. G. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01527.x · Cited by 141
Porritt, M. J., Batchelor, P. E., & Howells, D. W. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.11.030 · Cited by 135
The Role of Dopamine Receptors in Regulating the Size of Axonal Arbors
Parish, C. L., Finkelstein, D. I., Drago, J., Borrelli, E., & Horne, M. K. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05147.2001 · Cited by 132
Oo, T. F., Kholodilov, N. G., & Burke, R. E. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-12-05141.2003 · Cited by 131
Liang, C., Sinton, C. M., Sonsalla, P. K., & German, D. C. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0042 · Cited by 116
Hung, H.-C., & Lee, E. H. Y. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(96)00062-9 · Cited by 116
Studer, L., Spenger, C., Seiler, R. W., Altar, C. A., Lindsay, R. M., & Hyman, C. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb01058.x · Cited by 114
Prigent, A., Agid, Y., & Hirsch, É. C. (1994) · Brain Research · doi:10.1016/0006-8993(94)90511-8 · Cited by 107
Midbrain dopaminergic neurons in the mouse: co-localization with Calbindin-D28k and calretinin
Liang, C., Sinton, C. M., & German, D. C. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00228-x · Cited by 104
Hagg, T. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6684 · Cited by 99
Chang, M., Son, H., Lee, Y., & Lee, S. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00068-x · Cited by 98
Bennett, J. L., Zeiler, S. R., & Jones, K. R. (1999) · PubMed · Cited by 94
Self-citationGenetics of parkin-linked disease
West, A. B., & Maidment, N. T. (2004) · Human Genetics · doi:10.1007/s00439-003-1074-6 · Cited by 90
Kholodilov, N. G., Yarygina, O., Oo, T. F., Zhang, H., Sulzer, D., Dauer, W. T., & Burke, R. E. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4506-03.2004 · Cited by 87
BDNF attenuates the effects of intrastriatal injection of 6-hydroxydopamine
Shults, C. W., Kimber, T. A., & Altar, A. C. (1995) · Neuroreport · doi:10.1097/00001756-199505300-00009 · Cited by 85
Calbindin-D28k buffers intracellular calcium and promotes resistance to degeneration in PC12 cells
McMahon, A., Wong, B. S., Iacopino, A. M., Ng, M. C., Chi, S. N., & German, D. C. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00305-7 · Cited by 85
Gratacòs, E., Pérez‐Navarro, E., Tolosa, E. S., Arenas, E., & Alberch, J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00538.x · Cited by 84
van den Akker, E., Reijnen, M. J., Korving, J., Brouwer, A., Meijlink, F. C. P. W., & Deschamps, J. (1999) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00212-9 · Cited by 75
Differential effects of GDNF and BDNF on cultured ventral mesencephalic neurons
Feng, L., Wang, C.-Y., Jiang, H., Oho, C., Mizuno, K., Dugich‐Djordjevic, M. M., & Lu, B. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00015-7 · Cited by 67
Anterior cingulate cortical transplantation in transgenic Huntington’s disease mice
van Dellen, A., Deacon, R. M. J., York, D. F., Blakemore, C. B., & Hannan, A. J. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00655-4 · Cited by 66
Alterations in Nigrostriatal Dopaminergic Function within BDNF Mutant Mice
Dluzen, D. E., Story, G. M., Xu, K., Kučera, J., & Walro, J. M. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7225 · Cited by 65
Kohno, R., Sawada, H., Kawamoto, Y., Uemura, K., Shibasaki, H., & Shimohama, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.012 · Cited by 63
Medial nigral dopamine neurons have rich neurotrophin support in humans
Nishio, T., Furukawa, S., Akiguchi, I., & Sunohara, N. (1998) · Neuroreport · doi:10.1097/00001756-199808240-00030 · Cited by 59
Reiriz, J., Espejo, M., Ventura, F., Ambrosio, S., & Alberch, J. (1999) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(19990205)38:2<161::aid-neu1>3.0.co;2-3 · Cited by 57
Pre- and postnatal development of dopaminergic neuron numbers in the male and female mouse midbrain
Lieb, K., Andersen, C., Lazarov, N., Zienecker, R., Urban, I., Reisert, I., & Pilgrim, C. (1996) · Developmental Brain Research · doi:10.1016/0165-3806(96)00063-6 · Cited by 56
Motor abnormalities in weaver mutant mice
Lalonde, R. (1987) · Experimental Brain Research · doi:10.1007/bf00236322 · Cited by 55
Baker, S. A., Stanford, L. E., Brown, R. E., & Hagg, T. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.052 · Cited by 55
González‐Hernández, T., & Rodrı́guez, M. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000522)421:1<107::aid-cne7>3.3.co;2-6 · Cited by 53
Expression of neurotrophin-3 in the mouse forebrain: Insights from a targetedLacZ reporter
Vigers, A. J., Baquet, Z. C., & Jones, K. R. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000117)416:3<398::aid-cne10>3.0.co;2-p · Cited by 51
Self-citationMotor abnormalities in staggerer mutant mice
Lalonde, R. (1987) · Experimental Brain Research · doi:10.1007/bf00248807 · Cited by 49
Gratacós, E., Checa, N., Pérez-Navarro, E., & Alberch, J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00570.x · Cited by 48
Calretinin-containing axons and neurons are resistant to an intrastriatal 6-hydroxydopamine lesion
Tsuboi, K., Kimber, T. A., & Shults, C. W. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02219-8 · Cited by 41
Hattori, N., Shimura, H., Kubo, S., Kitada, T., Wang, M., Asakawa, S., Minashima, S., Shimizu, N., Suzuki, T., Tanaka, K., et al. (2000) · Neuropathology · doi:10.1046/j.1440-1789.2000.00312.x · Cited by 41
Kim, B. G., Shin, D. H., Jeon, G. S., Seo, J. H., Kim, Y. W., Jeon, B. S., & Cho, S. S. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02374-4 · Cited by 33
Venero, J. L., Vizuete, M., Revuelta, M., Vargas, C., Cano, J., & Machado, A. M. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7243 · Cited by 32
Neurodegenerative alterations in the nigrostriatal system of trkB hypomorphic mice
Zaman, V., Nelson, M. E., Gerhardt, G. A., & Rohrer, B. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.08.002 · Cited by 17
de Zafra, C. L. Z., David, D., Ujhelyi, L., Hudson, J. L., Gerhardt, G. A., Kaplan, P. L., & Bickford, P. C. (2004) · Brain Research · doi:10.1016/j.brainres.2003.12.058 · Cited by 13
Self-citation
Cited by
Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129
Brain-derived neurotrophic factor in neurodegenerative diseases
Zuccato, C., & Cattaneo, E. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.54 · Cited by 947
BDNF as a Promising Therapeutic Agent in Parkinson’s Disease
Palasz, E., Wysocka, A., Gasiorowska, A., Chalimoniuk, M., Niewiadomski, W., & Niewiadomska, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031170 · Cited by 504
“Silencing the gene encoding BDNF in mice resulted in the loss of dopaminergic neurons, which confirms the role of BDNF in protecting neurons against injury and degeneration [72,75,76].”
BackgroundNeuroplasticity of Neocortical Circuits in Schizophrenia
Lewis, D. A., & González-Burgos, G. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301563 · Cited by 365
How to make a mesodiencephalic dopaminergic neuron
Smidt, M. P., & Burbach, J. P. H. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2039 · Cited by 355
Metadata
- Authors
- Baquet, Z. C., Bickford, P. C., & Jones, K. R.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2005-06-29
- Volume
- 25
- Issue
- 26
- Pages
- 6251-6259
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2027603848
- Cited by
- 307
- References
- 94
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.